Combining Technology and PK/PD Expertise to Optimize Drug Development:
A New Era for Collaborative Environments in Translational Medicine
|
|
This webinar will introduce integrated approaches for data management, PK/PD analysis, reporting technology and automation to optimize drug development. Collaborative platforms for efficient translational medicine activities will also be presented. Through a series of case studies, this webinar will provide an overview of approaches and tools used by Pharsight in the drug development process for:
The case studies will be supplemented with data and insights from drug development organizations on challenges and opportunities for efficient clinical study design, execution and analysis. |
Sponsored by:
Pharsight® software products and scientific consulting services facilitate improved productivity and strategic decision making in drug development. Pharsight’s Reporting and Analysis Services (RAS) group is a highly skilled team of pharmaceutical scientists, biostatisticians, and technical experts committed to providing high-quality, regulatory-compliant PK/PD analysis, biostatistics, and reporting for new drug approval.
RAS scientists make use of Pharsight’s industry-leading software tools to provide analyses, data management and report writing for preclinical and clinical studies to support sponsor's new drug approval submissions. RAS serves all major drug development geographies, with business representatives in the United States, Europe, and Japan. RAS scientists bring experience to Pharsight representing more than 400 client engagements in the past several years. All RAS work is executed to the highest professional standards, in minimum time, at competitive rates.
